UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000048967
Receipt No. R000055789
Scientific Title Assessment of spontaneous inspiratory effort using inspiratory muscle echocardiography in patients with ARDS
Date of disclosure of the study information 2022/09/20
Last modified on 2022/09/20 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Assessment of spontaneous inspiratory effort using inspiratory muscle echocardiography in patients with ARDS
Acronym MUSCLE echo-ARDS study
Scientific Title Assessment of spontaneous inspiratory effort using inspiratory muscle echocardiography in patients with ARDS
Scientific Title:Acronym MUSCLE echo-ARDS study
Region
Japan

Condition
Condition Acute respiratory distress syndrome (ARDS)
Classification by specialty
Intensive care medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study investigate whether spontaneous inspiratory effort can be accurately assessed by diaphragmatic and intercostal muscle echocardiography in patients with ARDS
Basic objectives2 Others
Basic objectives -Others If we can confirm that noninvasive echocardiography can be used to evaluate spontaneous inspiratory effort without an intraesophageal pressure balloon
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes To determine whether the thickening fraction of diaphragmatic and intercostal muscle echoes can predict strong spontaneous breathing (delta Pes>10 cmH2O)
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria - Patients diagnosed with ARDS and undergoing invasive ventilatory management with PaO2/FiO2 < 150 mmHg
- Patients who require an esophageal pressure catheter for monitoring
Key exclusion criteria - There is a contraindication to esophageal pressure catheter insertion (varices, postoperative upper gastrointestinal tract, or other physician's judgment)
- History of neuromuscular disease (history of stroke not affecting respiratory muscles is not an exclusion)
- Intercostal muscle echocardiography is affected after an invasive intervention on the thorax, such as after cardiovascular surgery or thoracic surgery
- If thoracic deformity is present
- If the patient has chronic respiratory failure using home oxygen therapy or non-invasive ventilation
Target sample size 24

Research contact person
Name of lead principal investigator
1st name Jun
Middle name
Last name Kataoka
Organization Nerima Hikarigaoka Hospital
Division name Department of Critical Care Medicine
Zip code 179-0072
Address 2-11-1, Hikarigaoka, Nerima-ku, Tokyo, Japan
TEL 0339793611
Email rdcyc910@yahoo.co.jp

Public contact
Name of contact person
1st name Jun
Middle name
Last name Kataoka
Organization Nerima Hikarigaoka Hospital
Division name Department of Critical Care Medicine
Zip code 179-0072
Address 2-11-1, Hikarigaoka, Nerima-ku, Tokyo, Japan
TEL 0339793611
Homepage URL
Email rdcyc910@yahoo.co.jp

Sponsor
Institute Nerima Hikarigaoka Hospital
Institute
Department

Funding Source
Organization Not applicable
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor Department of Emergency and Critical Care Medicine, St. Marianna University
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethics committee, Nerima Hikarigaoka Hospital
Address 2-11-1, Hikarigaoka, Nerima-ku, Tokyo, Japan
Tel 0339793611
Email hidetoshiy@jadecom.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 09 Month 20 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2021 Year 02 Month 05 Day
Date of IRB
2021 Year 02 Month 18 Day
Anticipated trial start date
2021 Year 02 Month 18 Day
Last follow-up date
2023 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information - If the patient is on assisted ventilation (AC-PC or PSV) with spontaneous breathing, measure daily (up to day 7).
- Confirm that the patient is breathing steadily and record ventilator settings and arterial blood gas findings at that time.
- Diaphragmatic echo is measured in the ninth or tenth intercostal space between the mid-axilla or anterior axis
- Intercostal muscle echo is measured at the right margin of the sternum in the second intercostal space.
- A high-frequency linear probe is used and the probing site is marked for consistency of daily measurements.
- End-expiratory and end-inspiratory diameters are measured and recorded for three stable breaths.
- TFic and TFdi are calculated from end expiratory and end inspiratory diameters and averaged over 3 stable breaths
- Delta Pes and delta PL-dyn are measured as monitoring by esophageal pressure balloon. (When Hamilton G5/C6 is used, PTPes is also recorded in the same way.)
- If the ventilator is capable of measurement, P0.1 and delta Pocc are measured and the average of 3 stable breaths is calculated.
- Determine the need for continuous daily use of muscle relaxation; if there are strong spontaneous breaths and the clinician determines that muscle relaxation is needed, this should be clearly indicated.
- Measure Crs and Rrs after subsequent use of muscle relaxation

Management information
Registered date
2022 Year 09 Month 20 Day
Last modified on
2022 Year 09 Month 20 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055789